纤溶药物的抗血小板作用：溶栓后止血缺陷的一个潜在因素。 - Suppr

Antiplatelet effects of fibrinolytic agents: a potential contributor to the hemostatic defect after thrombolysis.

Kamat S G, Schafer A I

Hematology-Oncology Section, Baylor College of Medicine, Houston, Texas, USA.

Coron Artery Dis. 1995 Dec;6(12):930-5.

Abstract

摘要

Coron Artery Dis. 1995 Dec;6(12):930-5.

Coron Artery Dis. 1995 Dec;6(12):923-9.

Arch Pathol Lab Med. 1993 Jan;117(1):89-96.

Hematol Oncol Clin North Am. 1990 Feb;4(1):87-105.

Circulation. 2004 Nov 2;110(18):2946-51. doi: 10.1161/01.CIR.0000146341.63677.3C. Epub 2004 Oct 25.

J Physiol Pharmacol. 1995 Dec;46(4):409-18.

Cardiologia. 1998 Aug;43(8):825-32.

Am J Cardiol. 2007 Aug 15;100(4):722-7. doi: 10.1016/j.amjcard.2007.03.091. Epub 2007 Jun 26.

Expert Rev Cardiovasc Ther. 2004 Jul;2(4):535-45. doi: 10.1586/14779072.2.4.535.

Heart Lung Circ. 2007 Jun;16(3):176-9. doi: 10.1016/j.hlc.2007.03.004. Epub 2007 Apr 18.

Curr Cardiol Rep. 2002 Jul;4(4):301-12. doi: 10.1007/s11886-002-0066-9.

20分钟写一篇综述，助力文献阅读效率提升50倍。

大模型驱动的PubMed中文搜索引擎

学术文献翻译模型，支持多种主流文档格式。